Honolulu, Hawaii 2021-09-09 14:13:51 –
Norwood, MassachusettsNewsNation Now) — Moderna announced that it is developing a hybrid vaccine that provides protection against COVID-19 and influenza.
In a statement, Modana CEO Stephane Bancel announced today the first steps in a new respiratory vaccine program by developing a single-dose vaccine that combines a booster for COVID-19 and a booster for influenza. I will do it. “
Check out what’s happening all over our country National news page
The company has not yet received approval or approval for stand-alone influenza vaccination and only launched a Phase 1/2 investigation in July. A Moderna spokesman didn’t immediately return a request for comment on when the trial of this hybrid shot would start, or if he expected the two-in-one shot to be just as effective.
Moderna isn’t the only one trying to combine the flu with the COVID-19 vaccine. Novavax began clinical trials in Australia on Wednesday to test its shots. Results are expected in the first half of next year.
Combo vaccine news has benefited Moderna’s stock, which had risen by more than 6% by noon Thursday. With the launch of the COVID-19 vaccine, prices have risen by more than 300% year-to-date, and in anticipation, more companies are mandating shots to control delta variants.
President Joe Biden was speaking on Thursday Will announce a stricter mission For federal workers than what is being done.
Moderna is also developing four variant-specific booster candidates for standalone COVID-19 shots, including formulas specifically for deltas. There was no word about when they could be submitted for approval or approval from the Food and Drug Administration.
They also submitted a third booster application for the current vaccine to the FDA, which is half as effective as the first two doses. Recent studies have shown that Moderna’s products induce stronger levels of antibodies than Pfizer’s mRNA products, but experts say Moderna has more than twice as much active ingredient in a single dose. Because it is included.
Get news on the go KHON 2GO, KHON morning podcast, 8am every morning
Booster shots have become an increasingly controversial topic internationally. The World Health Organization has called on wealthy countries to postpone the third vaccination until other countries in the world can start vaccination programs. Just recently in August, US medical professionals disagreed on whether it was even necessary.
But they assembled it as a way to anticipate what they believe could be a wave of preventable infections as their immune system weakens.
“You can see the trend, get ready for it,” said Dr. Francis Collins, director of the National Institutes of Health. Said last month in NewsNation Prime..
In addition to the combination vaccine, research is underway on injections for respiratory syncytial virus (RSV), human metapneumovirus (hMPV), parainfluenza type 3 (PIV3), and experimental cancer vaccines, according to a news release. That is.
The company is also working on the “next generation” COVID-19 vaccine, which is in the initial testing phase.
Moderna working on hybrid COVID-19/Flu vaccine Source link Moderna working on hybrid COVID-19/Flu vaccine